Genotoxic effects of myosmine in a human esophageal adenocarcinoma cell line

Toxicology

Volumn 222, Issue 1-2, 2006, Pages 71-79

  Vogt, Sarah ^a   Fuchs, Katharina ^a   Richter, Elmar ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Comet assay; Esophageal cells; Genotoxicity; Myosmine

Indexed keywords

ALKALOID; CYCLOOXYGENASE 2 INHIBITOR; DNA; DNA FORMAMIDOPYRIMIDINE GLYCOSYLASE; HYDROGEN PEROXIDE; LINSIDOMINE; METHYLNITRONITROSOGUANIDINE; MYOSMINE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PEROXYNITRITE; UNCLASSIFIED DRUG;

ALKALINITY; ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CHRONIC INFLAMMATION; COMET ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DNA DETERMINATION; DNA STRAND BREAKAGE; ESOPHAGEAL ADENOCARCINOMA; EXCISION REPAIR; GASTROESOPHAGEAL REFLUX; GENOTOXICITY; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PH; PRIORITY JOURNAL;

ADENOCARCINOMA; ALKALOIDS; CELL LINE, TUMOR; COMET ASSAY; DNA DAMAGE; DNA-FORMAMIDOPYRIMIDINE GLYCOSYLASE; ESOPHAGEAL NEOPLASMS; HUMANS;

NICOTIANA TABACUM;

EID: 33646245660     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2006.01.025     Document Type: Article

References (64)

1. Altorki N. COX-2: a target for prevention and treatment of esophageal cancer. J. Surg. Res. 117 (2004) 114-120
2. Banki F., DeMeester S.R., Mason R.J., Campos G., Hagen J.A., Peters J.H., Bremner C.G., and DeMeester T.R. Barrett's esophagus in females: a comparative analysis of risk factors in females and males. Am. J. Gastroenterol. 100 (2005) 560-567
3. Bove M., Vieth M., Casselbrant A., Ny L., Lundell L., and Ruth M. Acid challenge to the esophageal mucosa: effects on local nitric oxide formation and its relation to epithelial functions. Digest. Dis. Sci. 50 (2005) 640-648
4. Boysen G., Kenney P.M.J., Upadhyaya P., Wang M., and Hecht S.S. Effects of benzyl isothiocyanate and 2-phenethyl isothiocyanate on benzo[a]pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolism in F-344 rats. Carcinogenesis 24 (2003) 517-525
5. Bryan N.S., Rassaf T., Maloney R.E., Rodriguez C.M., Saijo F., Rodriguez J.R., and Feelisch M. Cellular targets and mechanisms of nitros(yl)ation: an insight into their nature and kinetics in vivo. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 4308-4313
6. Buskens C.J., van Rees B.P., Sivula A., Reitsma J.B., Haglund C., Bosma P.J., Offerhaus G.J., van Lanschot J.J., and Ristimäki A. Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagus. Gastroenterology 122 (2002) 1800-1807
7. Chen X.X., and Yang C.S. Esophageal adenocarcinoma: a review and perspectives on the mechanism of carcinogenesis and chemoprevention. Carcinogenesis 22 (2001) 1119-1129
8. Cheong E., Igali L., Harvey I., Mole M., Lund E., Johnson I.T., and Rhodes M. Cyclo-oxygenase-2 expression in Barrett's oesophageal carcinogenesis: an immunohistochemical study. Aliment. Pharmacol. Therap. 17 (2003) 379-386
9. Cheong E., Ivory K., Doleman J., Parker M.L., Rhodes M., and Johnson I.T. Synthetic and naturally occurring COX-2 inhibitors suppress proliferation in a human oesophageal adenocarcinoma cell line (OE33) by inducing apoptosis and cell cycle arrest. Carcinogenesis 25 (2004) 1945-1952
10. Chow W.-H., Blot W.J., Vaughn T.L., Risch H.A., Gammon M.D., Stanford J.L., Dubrow R., Schoenberg J.B., Mayne S.T., Farrow D.C., Ahsan H., West A.B., Rotterdam H., Niwa S., and Fraumeni J.F. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J. Natl. Cancer Inst. 90 (1998) 150-155
11. Collins A.R., Dobson V.L., Dusinská M., Kennedy G., and Stetina R. The comet assay: what can it really tell us?. Mutat. Res. 375 (1997) 183-193
12. Collins A.R., and Horvathova E. Oxidative DNA damage, antioxidants and DNA repair: applications of the comet assay. Biochem. Soc. Trans. 29 (2001) 337-341
13. Corley D.A., Kerlikowske K., Verma R., and Buffler P. Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. Gastroenterology 124 (2003) 47-56
14. DeMeester S. Adenocarcinoma of the esophagus and cardia: a review of the disease and its treatment. Ann. Surg. Oncol. 13 (2005) 1-19
15. Doulias P.T., Barbouti A., Galaris D., and Ischiropoulos H. SIN-1-induced DNA damage in isolated human peripheral blood lymphocytes as assessed by single cell gel electrophoresis (comet assay). Free Radic. Biol. Med. 30 (2001) 679-685
16. Faust F., Kassie F., Knasmüller S., Boedecker R.H., Mann M., and Mersch-Sundermann V. The use of the alkaline comet assay with lymphocytes in human biomonitoring studies. Mutat. Res. 566 (2004) 209-229
17. Foiles P.G., Akerkar S.A., Carmella S.G., Kagan M., Stoner G.D., Resau J.H., and Hecht S.S. Mass spectrometric analysis of tobacco-specific nitrosamine DNA-adducts in smokers and nonsmokers. Chem. Res. Toxicol. 4 (1991) 364-368
18. Gerson S.L. MGMT: its role in cancer aetiology and cancer therapeutics. Nat. Rev. Cancer 4 (2004) 296-307
19. Goldstein S.R., Yang G.-Y., Chen X., Curtis S.K., and Yang C.S. Studies of iron deposits, inducible nitric oxide synthase and nitrotyrosine in a rat model for esophageal adenocarcinoma. Carcinogenesis 19 (1998) 1445-1449
20. Hecht S.S. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem. Res. Toxicol. 11 (1998) 559-603
21. Hecht S.S. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat. Rev. Cancer 3 (2003) 733-744
22. Hölzle D., Schlöbe D., Richter E., Ostermeier-Hatz D., von Meyer L., and Tricker A.R. 4-Hydroxy-1-(3-pyridyl)-1-butanone (HPB)-releasing DNA adducts in lung, esophagus and cardia of sudden death victims. Proc. Am. Ass. Cancer Res. 44 2nd ed. (2003) 1281-1282
23. Kleinsasser N.H., Wallner B.C., Harréus U.A., Zwickenpflug W., and Richter E. Genotoxic effects of myosmine in human lymphocytes and upper aerodigestive tract epithelial cells. Toxicology 192 (2003) 171-177
24. Lagergren J., Bergström R., and Nyrén O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann. Intern. Med. 130 (1999) 883-890
25. 6-methylguanine-DNA-methyltransferase. Carcinogenesis 15 (1994) 443-447
26. Lijinsky W. The significance of N-nitroso compounds as environmental carcinogens. J. Environ. Sci. Health C4 (1986) 1-45
27. Liu L.L., Qin X., and Gerson S.L. Reduced lung tumorigenesis in human methylguanine DNA-methyltransferase transgenic mice achieved by expression of transgene within the target cell. Carcinogenesis 20 (1999) 279-284
28. Maier M., Schulze A., and Richter E. Biomonitoring of myosmine in human milk and saliva. Toxicol. Lett. 158 (2005) S201-S202
29. Martin-Romero F.J., Gutierrez-Martin Y., Henao F., and Gutierrez-Merino C. Fluorescence measurements of steady state peroxynitrite production upon SIN-1 decomposition: NADH versus dihydrodichlorofluorescein and dihydrorhodamine 123. J. Fluoresc. 14 (2004) 17-23
30. 6-Pyridyloxobutylguanine adducts contribute to the mutagenic properties of pyridyloxobutylating agents. Chem. Res. Toxicol. 18 (2005) 1619-1625
31. 6-alkylguanine-DNA alkyltransferase variants. Chem. Res. Toxicol. 17 (2004) 424-434
32. Moriya A., Grant J., Mowat C., Williams C., Carswell A., Preston T., Anderson S., Iijima K., and McColl K.E.L. In vitro studies indicate that acid catalysed generation of N-nitrosocompounds from dietary nitrate will be maximal at the gastro-oesophageal junction and cardia. Scand. J. Gastroenterol. 37 (2002) 253-261
33. Mörk H., Scheurlen M., Al-Taie O., Zierer A., Kraus M., Schöttker K., Jakob F., and Köhrle J. Glutathione peroxidase isoforms as part of the local antioxidative defense system in normal and Barrett's esophagus. Int. J. Cancer 105 (2003) 300-304
34. 6-alkylguanine-DNA alkyltransferase. J. Med. Chem. 47 (2004) 3887-3891
35. Olliver J.R., Hardie L.J., Gong Y., Dexter S., Chalmers D., Harris K.M., and Wild C.P. Risk factors, DNA damage, and disease progression in Barrett's esophagus. Cancer Epidemiol. Biomar. Prev. 14 (2005) 620-625
36. 6-[4-oxo-4-(3-pyridyl)butyl]guanine in Escherichia coli and human cells. Chem. Res. Toxicol. 15 (2002) 165-169
37. Pegg A.E. Repair of O(6)-alkylguanine by alkyltransferases. Mutat. Res. 462 (2000) 83-100
38. Peto R., Gray R., Brantom P., and Grasso P. Dose and time relationships for tumor induction in the liver and esophagus of 4080 inbred rats by chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine. Cancer Res. 51 (1991) 6452-6469
39. Powell J., McConkey C.C., Gillison E.W., and Spychal R.T. Continuing rising trend in oesophageal adenocarcinoma. Int. J. Cancer 102 (2002) 422-427
40. Rioux N., and Castonguay A. Prevention of NNK-induced lung tumorigenesis in A/J mice by acetylsalicylic acid and NS-398. Cancer Res. 58 (1998) 5354-5360
41. Shao L., Lin J., Huang M., Ajani J.A., and Wu X. Predictors of esophageal cancer risk: assessment of susceptibility to DNA damage using comet assay. Genes Chromosomes Cancer 44 (2005) 415-422
42. Shin V.Y., Wu W.K.K., Ye Y.-N., So W.H.L., Koo M.W.L., Liu E.S.L., Luo J.-C., and Cho C.-H. Nicotine promotes gastric tumor growth and neovascularization by activating extracellular signal-regulated kinase and cyclooxygenase-2. Carcinogenesis 25 (2004) 2487-2495
43. Sihvo E.I.T., Salminen J.T., Rantanen T.K., Rämö O.J., Ahotupa M., Färkkilä M., Auvinen M.I., and Salo J.A. Oxidative stress has a role in malignant transformation in Barrett's oesophagus. Int. J. Cancer 102 (2002) 551-555
44. Singh R.J., Hogg N., Joseph J., Konorev E., and Kalyanaraman B. The peroxynitrite generator, SIN-1, becomes a nitric oxide donor in the presence of electron acceptors. Arch. Biochem. Biophys. 361 (1999) 331-339
45. Sticha K.R.K., Kenney P.M.J., Boysen G., Liang H., Su X., Wang M., Upadhyaya P., and Hecht S.S. Effects of benzyl isothiocyanate and phenethyl isothiocyanate on DNA adduct formation by a mixture of benzo[a]pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mouse lung. Carcinogenesis 23 (2002) 1433-1439
46. Suzuki H., Iijima K., Moriya A., McElroy K., Scobie G., Fyfe V., and McColl K.E.L. Conditions for acid catalysed luminal nitrosation are maximal at the gastric cardia. Gut 52 (2003) 1095-1101
47. Suzuki H., Iijima K., Scobie G., Fyfe V., and McColl K.E.L. Nitrate and nitrosative chemistry within Barrett's oesophagus during acid reflux. Gut 54 (2005) 1527-1535
48. Terry P., Lagergren J., Hansen H., Wolk A., and Nyrén O. Fruit and vegetable consumption in the prevention of oesophageal and cardia cancers. Eur. J. Cancer Prev. 10 (2001) 365-369
49. Terry P., Lagergren J., Ye W., Nyrén O., and Wolk A. Antioxidants and cancers of the esophagus and gastric cardia. Int. J. Cancer 87 (2000) 750-754
50. Tselepis C., Morris C.D., Wakelin D., Hardy R., Perry I., Luong Q.T., Harper E., Harrison R., Attwood S.E., and Jankowski J.A. Upregulation of the oncogene c-myc in Barrett's adenocarcinoma: induction of c-myc by acidified bile acid in vitro. Gut 52 (2003) 174-180
51. Tyroller S., Zwickenpflug W., and Richter E. New sources of dietary myosmine uptake from cereals, fruits, vegetables and milk. J. Agric. Food Chem. 50 (2002) 4909-4915
52. Upadhyaya P., Sturla S.J., Tretyakova N., Ziegel R., Villalta P.W., Wang M.Y., and Hecht S.S. Identification of adducts produced by the reaction of 4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanol with deoxyguanosine and DNA. Chem. Res. Toxicol. 16 (2003) 180-190
53. von Rahden B.H.A., Stein H.J., Pühringer F., Koch I., Langer R., Piontek G., Siewert J.R., Höfler H., and Sarbia M. Coexpression of cyclooxygenases (COX-1, COX-2) and vascular endothelial growth factors (VEGF-A, VEGF-C) in esophageal adenocarcinoma. Cancer Res. 65 (2005) 5038-5044
54. 6-alkylguanine-DNA alkyltransferase. Chem. Res. Toxicol. 10 (1997) 562-567
55. Wang M., Cheng G., Sturla S.J., Shi Y., McIntee E.J., Villalta P.W., Upadhyaya P., and Hecht S.S. Identification of adducts formed by pyridyloxobutylation of deoxyguanosine and DNA by 4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone, a chemically activated form of tobacco specific carcinogens. Chem. Res. Toxicol. 16 (2003) 616-626
56. Wild C.P., and Hardie L.J. Reflux, Barrett's oesophagus and adenocarcinoma: burning questions. Nature Rev. Cancer 3 (2003) 676-685
57. Wilp J., Zwickenpflug W., and Richter E. Nitrosation of dietary myosmine as risk factor of human cancer. Food Chem. Toxicol. 40 (2002) 1223-1228
58. Wilson K.T., Fu S., Ramanujam K.S., and Meltzer S.J. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas. Cancer Res. 58 (1998) 2929-2934
59. Wu A.H., Wan P., and Bernstein L. A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus (United States). Cancer Cause Control 12 (2001) 721-732
60. Yu H., Venkatarangan L., Wishnok J.S., and Tannenbaum S.R. Quantitation of four Guanine oxidation products from reaction of DNA with varying doses of peroxynitrite. Chem. Res. Toxicol. 18 (2005) 1849-1857
61. Zimmermann K.C., Sarbia M., Weber A.-A., Borchard F., Gabbert H.E., and Schrör K. Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res. 59 (1999) 198-204
62. Zwickenpflug W. N-nitrosation of myosmine yields HPB (4-hydroxy-1-(3-pyridyl)-1-butanone) and NNN (N-nitrosonornicotine). J. Agric. Food Chem. 48 (2000) 392-394
63. Zwickenpflug W., Meger M., and Richter E. Occurrence of the tobacco alkaloid myosmine in nuts and nut products of Arachus hypogaea and Corylus avellana. J. Agric. Food Chem. 46 (1998) 2703-2706
64. Zwickenpflug, W., Tyroller, S., 2005. Reaction of the tobacco alkaloid myosmine with hydrogen peroxide. Chem. Res. Toxicol. [epub ahead].